Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation
暂无分享,去创建一个
J. Sierra | A. Jiménez | S. Brunet | G. Sanz | A. Torres | D. Gallardo | R. Cámara | C. Martin | D. Serrano | E. Carreras | D. Caballero | C. Sanz-Rodríguez | J. Berlanga | J. Vallejo | I. Espigado
[1] M. Labopin,et al. Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation , 2003, Leukemia.
[2] J Hermans,et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation , 1998, The Lancet.
[3] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[4] R. Hoffmann,et al. Risk factors for acute graft‐versus‐host disease , 1987, British journal of haematology.
[5] H. Deeg,et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. , 1992, Blood.